Connective Tissue Disorders and Ehlers-Danlos Syndrome
This is a recorded version of the webinar on Connective Tissue Disorders and Ehlers-Danlos Syndrome that was presented live on November 15, 2019. Please scroll all the way down this page to view the archived webinar.
Webinar Launch Date: 11/15/19
Estimated Time to complete: 1 hour
Format: Archived Webinar
Target Audience: Primary Care Physicians, Specialty Physicians (Ob/Gyn, Oncology, Hematology), Physician Assistants, Advanced Nurse Practitioners, Registered Nurses, Licensed Practical Nurses, Registered Nurses in Specialty Areas (Ob/Gyn, Oncology, Hematology), Physical Therapists
This state-of-the-science Webinar will explore the care of women and girls with connective tissue disorders, including a special focus on Ehlers-Danlos Syndrome. The faculty will address specific issues and needs that individuals with connective tissue disorders may have; differentiate between the various types of connective tissue disorders; discuss comorbidities between hypermobility and bleeding disorders; describe the treatment strategies that are recommended for symptom management, and describe the importance of collaboration between disciplines for effective management and treatment.
The relationship between hypermobility and bleeding has long been established. Even so, there’s still much that specialists in each area can learn from one another. There is a lack of knowledge among providers particularly regarding Ehlers-Danlos Syndrome; many hematologists see patients with bleeding symptoms but have no bleeding disorder even though they have significant joint mobility. Women with hypermobility are more resistant to standard treatment than those without, and greater knowledge on the part of the provider can help improve evaluation, treatment, and outcomes.
After completing this educational activity, participants should be able to:
- Describe the medical complications that individuals with connective tissue disorders may have
- Differentiate between the various types of connective tissue disorders
- Discuss comorbidities between hypermobility and bleeding disorders
- Identify the relationship between patients with hypermobility and bleeding, and how they may be more resistant to standard treatment
- Discuss recommended strategies for the optimal management and treatment of the clinical complications that affect female patients with connective tissue disorders may have, including care related to heavy bleeding
- Discuss ways in which collaboration between disciplines augments management and treatment of patients with connective tissue disorders
Pamela L. Trapane, MD
Professor, Department of Pediatrics
Chief, Pediatric Genetics
University of Florida Health
Sarah H. O'Brien, MD, MSc
Associate Professor, Hematology/Oncology
Director of Experimental Therapeutics
Section of Hematology/Oncology/BMT
Nationwide Children's Hospital